2vr6
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2vr6]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VR6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2VR6 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2vr6]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VR6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2VR6 FirstGlance]. <br> | ||
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1l3n|1l3n]], [[2af2|2af2]], [[1uxl|1uxl]], [[1ptz|1ptz]], [[1oez|1oez]], [[1rk7|1rk7]], [[1hl4|1hl4]], [[1azv|1azv]], [[2v0a|2v0a]], [[2c9s|2c9s]], [[4sod|4sod]], [[1mfm|1mfm]], [[1ozu|1ozu]], [[1dsw|1dsw]], [[1ozt|1ozt]], [[1kmg|1kmg]], [[2c9v|2c9v]], [[1n18|1n18]], [[1ba9|1ba9]], [[1pu0|1pu0]], [[1fun|1fun]], [[1sos|1sos]], [[1n19|1n19]], [[2c9u|2c9u]], [[1hl5|1hl5]], [[1p1v|1p1v]], [[1uxm|1uxm]], [[1spd|1spd]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1l3n|1l3n]], [[2af2|2af2]], [[1uxl|1uxl]], [[1ptz|1ptz]], [[1oez|1oez]], [[1rk7|1rk7]], [[1hl4|1hl4]], [[1azv|1azv]], [[2v0a|2v0a]], [[2c9s|2c9s]], [[4sod|4sod]], [[1mfm|1mfm]], [[1ozu|1ozu]], [[1dsw|1dsw]], [[1ozt|1ozt]], [[1kmg|1kmg]], [[2c9v|2c9v]], [[1n18|1n18]], [[1ba9|1ba9]], [[1pu0|1pu0]], [[1fun|1fun]], [[1sos|1sos]], [[1n19|1n19]], [[2c9u|2c9u]], [[1hl5|1hl5]], [[1p1v|1p1v]], [[1uxm|1uxm]], [[1spd|1spd]]</td></tr> |
- | <tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Superoxide_dismutase Superoxide dismutase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.15.1.1 1.15.1.1] </span></td></tr> | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Superoxide_dismutase Superoxide dismutase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.15.1.1 1.15.1.1] </span></td></tr> |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2vr6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vr6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2vr6 RCSB], [http://www.ebi.ac.uk/pdbsum/2vr6 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2vr6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vr6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2vr6 RCSB], [http://www.ebi.ac.uk/pdbsum/2vr6 PDBsum]</span></td></tr> |
- | <table> | + | </table> |
== Disease == | == Disease == | ||
[[http://www.uniprot.org/uniprot/SODC_HUMAN SODC_HUMAN]] Defects in SOD1 are the cause of amyotrophic lateral sclerosis type 1 (ALS1) [MIM:[http://omim.org/entry/105400 105400]]. ALS1 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms.<ref>PMID:12963370</ref> <ref>PMID:19741096</ref> <ref>PMID:8528216</ref> <ref>PMID:8682505</ref> <ref>PMID:9541385</ref> <ref>PMID:12754496</ref> <ref>PMID:15056757</ref> <ref>PMID:18378676</ref> [:]<ref>PMID:8446170</ref> <ref>PMID:8351519</ref> <ref>PMID:8179602</ref> <ref>PMID:7980516</ref> <ref>PMID:8069312</ref> <ref>PMID:7951252</ref> <ref>PMID:7881433</ref> <ref>PMID:7836951</ref> <ref>PMID:7997024</ref> <ref>PMID:7870076</ref> <ref>PMID:7887412</ref> <ref>PMID:7795609</ref> <ref>PMID:7655468</ref> <ref>PMID:7655469</ref> <ref>PMID:7655471</ref> <ref>PMID:7700376</ref> <ref>PMID:7647793</ref> <ref>PMID:7501156</ref> <ref>PMID:7496169</ref> <ref>PMID:8938700</ref> <ref>PMID:8907321</ref> <ref>PMID:8990014</ref> <ref>PMID:9101297</ref> <ref>PMID:9455977</ref> <ref>PMID:10732812</ref> <ref>PMID:9131652</ref> <ref>PMID:10400992</ref> <ref>PMID:10430435</ref> <ref>PMID:11535232</ref> <ref>PMID:11369193</ref> <ref>PMID:12402272</ref> <ref>PMID:12145308</ref> <ref>PMID:14506936</ref> <ref>PMID:18552350</ref> <ref>PMID:18301754</ref> <ref>PMID:21247266</ref> <ref>PMID:21220647</ref> | [[http://www.uniprot.org/uniprot/SODC_HUMAN SODC_HUMAN]] Defects in SOD1 are the cause of amyotrophic lateral sclerosis type 1 (ALS1) [MIM:[http://omim.org/entry/105400 105400]]. ALS1 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms.<ref>PMID:12963370</ref> <ref>PMID:19741096</ref> <ref>PMID:8528216</ref> <ref>PMID:8682505</ref> <ref>PMID:9541385</ref> <ref>PMID:12754496</ref> <ref>PMID:15056757</ref> <ref>PMID:18378676</ref> [:]<ref>PMID:8446170</ref> <ref>PMID:8351519</ref> <ref>PMID:8179602</ref> <ref>PMID:7980516</ref> <ref>PMID:8069312</ref> <ref>PMID:7951252</ref> <ref>PMID:7881433</ref> <ref>PMID:7836951</ref> <ref>PMID:7997024</ref> <ref>PMID:7870076</ref> <ref>PMID:7887412</ref> <ref>PMID:7795609</ref> <ref>PMID:7655468</ref> <ref>PMID:7655469</ref> <ref>PMID:7655471</ref> <ref>PMID:7700376</ref> <ref>PMID:7647793</ref> <ref>PMID:7501156</ref> <ref>PMID:7496169</ref> <ref>PMID:8938700</ref> <ref>PMID:8907321</ref> <ref>PMID:8990014</ref> <ref>PMID:9101297</ref> <ref>PMID:9455977</ref> <ref>PMID:10732812</ref> <ref>PMID:9131652</ref> <ref>PMID:10400992</ref> <ref>PMID:10430435</ref> <ref>PMID:11535232</ref> <ref>PMID:11369193</ref> <ref>PMID:12402272</ref> <ref>PMID:12145308</ref> <ref>PMID:14506936</ref> <ref>PMID:18552350</ref> <ref>PMID:18301754</ref> <ref>PMID:21247266</ref> <ref>PMID:21220647</ref> | ||
Line 39: | Line 39: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Superoxide dismutase]] | [[Category: Superoxide dismutase]] | ||
- | [[Category: Antonyuk, S | + | [[Category: Antonyuk, S]] |
- | [[Category: Cao, X | + | [[Category: Cao, X]] |
- | [[Category: Cohlberg, J A | + | [[Category: Cohlberg, J A]] |
- | [[Category: Doucette, P A | + | [[Category: Doucette, P A]] |
- | [[Category: Hart, P J | + | [[Category: Hart, P J]] |
- | [[Category: Hasnain, S S | + | [[Category: Hasnain, S S]] |
- | [[Category: Hayward, L J | + | [[Category: Hayward, L J]] |
- | [[Category: Holloway, S P | + | [[Category: Holloway, S P]] |
- | [[Category: Padua, S | + | [[Category: Padua, S]] |
- | [[Category: Seetharaman, S V | + | [[Category: Seetharaman, S V]] |
- | [[Category: Strange, R W | + | [[Category: Strange, R W]] |
- | [[Category: Taylor, A B | + | [[Category: Taylor, A B]] |
- | [[Category: Tiwari, A | + | [[Category: Tiwari, A]] |
- | [[Category: Valentine, J Selverstone | + | [[Category: Valentine, J Selverstone]] |
- | [[Category: Whitson, L J | + | [[Category: Whitson, L J]] |
[[Category: Amyotrophic lateral sclerosis]] | [[Category: Amyotrophic lateral sclerosis]] | ||
[[Category: Antioxidant]] | [[Category: Antioxidant]] |
Revision as of 16:34, 19 January 2015
CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.3 A RESOLUTION
|
Categories: Homo sapiens | Superoxide dismutase | Antonyuk, S | Cao, X | Cohlberg, J A | Doucette, P A | Hart, P J | Hasnain, S S | Hayward, L J | Holloway, S P | Padua, S | Seetharaman, S V | Strange, R W | Taylor, A B | Tiwari, A | Valentine, J Selverstone | Whitson, L J | Amyotrophic lateral sclerosis | Antioxidant | Disease mutation | Human cu | Metal-binding | Oxidoreductase | Zn superoxide dismutase